指南与共识妇科

西班牙裔/拉丁裔宫颈癌亚群生存率与指南一致性诊疗差异相关

Survival rates in Hispanic/Latinx subpopulations with cervical cancer associated with disparities in guideline-concordant care.
指南 / 共识 · Gynecol Oncol · 2024-02-09

基于美国国家癌症数据库2004至2019年95,589例原发性宫颈癌患者,研究分析西班牙裔/拉丁裔亚群接受指南一致性诊疗与生存率的关系。西班牙裔/拉丁裔和非西班牙裔黑人分别在9项质量指标中的4项和5项上较少接受指南一致性诊疗,但西班牙裔/拉丁裔组在9项指标中的7项上生存结局更好。

要点

  • 西班牙裔/拉丁裔和非西班牙裔黑人分别在9项质量指标中的4项和5项上较少接受指南一致性诊疗。
  • 西班牙裔/拉丁裔组在9项质量指标中的7项上生存结局优于其他组。
  • 古巴裔患者接受早期宫颈癌及时治疗的可能性是墨西哥裔患者的1.17倍(RR 1.17,95%CI 1.04-1.37,p<0.001)。

核心结论

  • 尽管接受了指南一致性诊疗,队列中仍存在显著生存差异,西班牙裔/拉丁裔人群生存率明显更高。

研究设计与样本

  • 分析2004至2019年美国国家癌症数据库中95,589例原发性宫颈癌患者,基于2009年FIGO分期制定9项质量指标。
  • 采用卡方检验分析临床和人口学协变量,多变量边际泊松回归分析指南一致性诊疗与种族/族裔的校正关联,Cox比例风险模型评估生存概率。

主要发现

  • 西班牙裔/拉丁裔和非西班牙裔黑人分别在9项质量指标中的4项和5项上较少接受指南一致性诊疗。
  • 西班牙裔/拉丁裔组在9项质量指标中的7项上生存结局更好。
  • 与墨西哥裔患者相比,古巴裔患者接受早期疾病及时治疗的可能性为1.17倍(RR 1.17,95%CI 1.04-1.37,p<0.001)。
  • 波多黎各裔和多米尼加裔患者接受早期疾病及时治疗的可能性分别为1.16倍(RR 1.16,95%CI 1.07-1.27,p<0.001)和1.19倍(RR 1.19,95%CI 1.04-1.37,p>0.01)。
  • 南美或中美洲裔患者接受局部晚期疾病及时治疗的可能性更高(RR 1.18,95%CI 1.10-1.27,p<0.001)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Failure to deliver guideline-concordant treatment may contribute to disparities among Hispanic/Latinx cervical cancer patients. This study investigated the association between survival rates in Hispanic/Latinx subpopulations and the provision of guideline-concordant care. METHODS: We analyzed patients with primary cervical cancer from 2004 to 2019 (National Cancer Database). We developed nine quality metrics based on FIGO staging (2009). Clinical and demographic covariates were analyzed using Chi-squared tests. Adjusted associations between receipt of guideline-concordant care and races and ethnicities were analyzed using multivariable marginal Poisson regression models. Adjusted Cox proportional hazard models were utilized to evaluate survival probability. RESULTS: A total of 95,589 patients were included. Hispanic/Latinx and Non-Hispanic Black (NHB) populations were less likely to receive guideline-concordant care in four and five out of nine quality metrics, respectively. Nonetheless, the Hispanic/Latinx group exhibited better survival outcomes in seven of nine quality metrics. Compared to Mexican patients, Cuban patients were 1.17 times as likely to receive timely initiation of treatment in early-stage disease (RR 1.17, 95% CI 1.04-1.37, p < 0.001). Puerto Rican and Dominican patients were, respectively, 1.16 (RR 1.16, 95% CI 1.07-1.27, p < 0.001) and 1.19 (RR 1.19, 95% 1.04-1.37, p > 0.01) times as likely to undergo timely initiation of treatment in early-stage disease. Patients of South or Central American (RR 1.18, 95% CI 1.10-1.27, p < 0.001) origin were more likely to undergo timely initiation of treatment in locally advanced disease. CONCLUSION: Significant differences in survival were identified among our cohort despite the receipt of guideline concordant care, with notably higher survival among Hispanic/Latinx populations.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Dinicu AI, Dioun S, Wang Y, et al. Survival rates in Hispanic/Latinx subpopulations with cervical cancer associated with disparities in guideline-concordant care. Gynecol Oncol. 2024. PMID: 38340647. doi:10.1016/j.ygyno.2024.01.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。